Dr. Madan Jagasia M.B.B.S, M.S


Dr. Jagasia specializes in stem cell transplant for hematological malignancies (leukemia, lymphoma, Myeloma, MDS) and bone marrow disorders. He is the Director, outpatient Transplant Programme at Vanderbilt-Ingram Cancer Center (VICC). VICC is a National Cancer Institute-designated Comprehensive Cancer Center, one of just two centers in Tennessee and 47 in the country to earn this highest distinction, and ranks in the top 10 nationwide for cancer research grant support.


  • Graft Versus Host Disease.
  • Clinical trials in GVHD, new drugs in leukemia, lymphoma and myeloma. 
  • Novel preparative regimen for stem cell transplant.

Professional highlights:

  • Co-Leader, Translational Research and Interventional Oncology Research Program, 
  • Professor of Medicine (Hematology/Oncology), Vanderbilt University Medical Centre.
  • Director, Outpatient Transplant Program, Vanderbilt-Ingram Cancer Center (VICC).
  • Section Chief, Hematology and Stem Cell Transplant, Vanderbilt University Medical Centre (2010-2014)